A prospective single‐center, single‐arm, open‐label, phase II study of sintilimab and anlotinib combined with chemotherapy in neoadjuvant treatment of resectable esophageal cancer.

Saved in:
Bibliographic Details
Title: A prospective single‐center, single‐arm, open‐label, phase II study of sintilimab and anlotinib combined with chemotherapy in neoadjuvant treatment of resectable esophageal cancer.
Authors: Duan, Hongtao1 (AUTHOR), Wang, Zhaoyang1 (AUTHOR), Cao, Lili2 (AUTHOR), Zhu, Yifang1 (AUTHOR) zyfdht321@sina.com, Tong, Liping1 (AUTHOR) 281071642@qq.com, Yan, Xiaolong1 (AUTHOR) yanxiaolong@fmmu.edu.cn
Source: Thoracic Cancer. Jul2024, Vol. 15 Issue 19, p1471-1476. 6p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 178211247
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A prospective single‐center, single‐arm, open‐label, phase II study of sintilimab and anlotinib combined with chemotherapy in neoadjuvant treatment of resectable esophageal cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Duan%2C+Hongtao%22">Duan, Hongtao</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Zhaoyang%22">Wang, Zhaoyang</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cao%2C+Lili%22">Cao, Lili</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhu%2C+Yifang%22">Zhu, Yifang</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> zyfdht321@sina.com</i><br /><searchLink fieldCode="AR" term="%22Tong%2C+Liping%22">Tong, Liping</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> 281071642@qq.com</i><br /><searchLink fieldCode="AR" term="%22Yan%2C+Xiaolong%22">Yan, Xiaolong</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> yanxiaolong@fmmu.edu.cn</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Thoracic+Cancer%22">Thoracic Cancer</searchLink>. Jul2024, Vol. 15 Issue 19, p1471-1476. 6p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=178211247
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/1759-7714.15312
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 6
        StartPage: 1471
    Titles:
      – TitleFull: A prospective single‐center, single‐arm, open‐label, phase II study of sintilimab and anlotinib combined with chemotherapy in neoadjuvant treatment of resectable esophageal cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Duan, Hongtao
      – PersonEntity:
          Name:
            NameFull: Wang, Zhaoyang
      – PersonEntity:
          Name:
            NameFull: Cao, Lili
      – PersonEntity:
          Name:
            NameFull: Zhu, Yifang
      – PersonEntity:
          Name:
            NameFull: Tong, Liping
      – PersonEntity:
          Name:
            NameFull: Yan, Xiaolong
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: Jul2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 17597706
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 19
          Titles:
            – TitleFull: Thoracic Cancer
              Type: main
ResultId 1